Fingerprint
Dive into the research topics of 'Insulin glargine 300 U/mL versus first-generation basal insulin analogues in insulin-naïve adults with type 2 diabetes: 12-month outcomes of ACHIEVE Control, a prospective, randomized, pragmatic real-life clinical trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically